Tumor necrosis factor gene polymorphisms and inflammatory response in coronary artery bypass grafting patients

Scandinavian Cardiovascular Journal

Volumn 38, Issue 3, 2004, Pages 172-177

  Westerberg, Martin ^a   Bengtsson, Anders ^a   Ricksten, Anne ^a   Jeppsson, Anders ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CABG; Gene polymorphism; Systemic inflammatory response; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; FEMALE; FLUORESCENCE ANALYSIS; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; ALLELES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142763280     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430410031795     Document Type: Article

References (23)

1. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111: S460-S475.
2. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996: 94: 2787-2792.
3. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297-302.
4. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation 1994; 90: 694-699.
5. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: Clinical and biological implications. Microsc Res Tech 2000; 50: 216-228.
6. Keso T, Perola M, Laippala P, et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154: 691-697.
7. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
8. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384.
9. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-244.
10. Wan S, LeClerc JL, Vincent JL, DeSmet JM, Barvais L, Goldstein M. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676 692.
11. Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol 1999: 118: 242-246.
12. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA 2001; 286: 2107-2113.
13. Koukkunen H, Penttila K, Kemppainen A, et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 2001; 33: 37-47.
14. Shah SH, Newby LK. C-reactive protein: A novel marker of cardiovascular risk. Cardiol Rev 2003; 11: 169-179.
15. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000; 100: 263-269.
16. Wang XL, Oosterhof J. Tumour necrosis factor alpha G-308-> A polymorphism and risk for coronary artery disease. Clin Sci (Lond) 2000; 98: 435-437.
17. Vendrell J, Fernandez-Real JM, Gutierrez C, et al. A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 2003; 167: 257-264.
18. Bernard V, Pillois X, Dubus I, et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: A risk factor for unstable angina. Clin Chem Lab Med 2003; 41: 511-516.
19. Herrmann SM, Ricard S, Nicaud V, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28: 59-66.
20. Schroeder SBN, Wrigge H, Welz A, Putensen C, Hoeft A, Stüber F. A tumor necrosis factor gene polymorphism influences the inflammatory response after cardiac operation. Ann Thorac Surg 2003; 75: 534-537.
21. Fugger L, Morling N, Ryder LP, et al. Ncol restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989; 30: 185-189.
22. Marano CW, Garulacan LA, Laughlin KV, et al. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass. Ann Thorac Surg 2000; 70: 1313-1318.
23. Tomasdottir H, Hjartarson H, Ricksten A, Wasslavik C, Bengtsson A, Ricksten SE. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg 2003; 97: 944-949.